journal article·2016-07

Simple emulsion technique as an innovative template for preparation of porous, spongelike poly(lactide-co-glycolide) microspheres with pore-closing capability

Youngme Lee, Hongkee Sah

Journal of Materials Science· Volume 51· Issue 13
Publisher page

Abstract

The objective of this study was to develop a new oil-in-water emulsion template for the preparation of highly porous poly(lactide-co-glycolide) (PLGA) microspheres having a spongelike skeleton and a pore-closing functionality. A dispersed phase consisting of isopropyl formate and PLGA was emulsified in an aqueous phase. Ammonia was added toward this emulsion, in order to induce ammonolysis in the dispersed phase. Subsequently, isopropyl formate was broken into water-soluble isopropanol and formamide. As they functioned as anti-solvents against PLGA, microsphere hardening occurred. Also, their leaching into the aqueous phase led to the formation of highly porous, spongelike microspheres. The microsphere porosity was found to be controlled by adjusting isopropyl formate volume, PLGA type and concentration, ammonia volume, and ammonia–isopropyl formate molar ratio. When these dried microspheres were dispersed into an aqueous phase, the pores closed themselves autonomously. Herein, the self-closing capability of the microspheres was greatly influenced by microsphere Tg and the aqueous phase temperature. FITC-dextran and lysozyme were successfully encapsulated into the microspheres by simply equilibrating their aqueous solutions with the self-closing microspheres. In conclusion, the new emulsion template did not use either a halogenated organic solvent or conventional porogens. It did not require high-shear or high-energy mixing devices that must be used in the practice of most contemporary microencapsulation techniques. Despite these facts, this new technique was able to fabricate spongelike microspheres with an extremely high porosity and an outstanding pore-closing functionality.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Hydrogels: synthesis, properties, applications · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Kim H, Park H, Lee J et al. (2011) Highly porous large poly(lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes. Biomaterials 32:1685–169310.1016/j.biomaterials.2010.10.045 ↗
2. Chung HJ, Kim HK, Yoon JJ, Park TG (2006) Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm Res 23:1835–184110.1007/s11095-006-9039-9 ↗
3. Sah H (1999) Protein behavior at the water/methylene chloride interface. J Pharm Sci 88:1320–132510.1021/js9900654 ↗
4. Draghi L, Resta S, Pirozzolo MG, Tanzi MC (2005) Microspheres leaching for scaffold porosity control. J Mater Sci Mater M 16:1093–109710.1007/s10856-005-4711-x ↗
5. Ravivarapu HB, Lee H, DeLuca PP (2000) Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharm Dev Technol 5:287–29610.1081/PDT-100100543 ↗
6. Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C (2007) NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J Control Release 121:100–10910.1016/j.jconrel.2007.05.039 ↗
7. Lin HR, Kuo CJ, Yang CY, Shaw SY, Wu YJ (2002) Preparation of macroporous biodegradable PLGA scaffolds for cell attachment with the use of mixed salts as porogen additives. J Biomed Mater Res 63:271–27910.1002/jbm.10183 ↗
8. Alcalá-Alcalá S, Urbán-Morlán Z, Aguilar-Rosas I, Quintanar-Guerrero D (2013) A biodegradable polymeric system for peptide–protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process. Int J Nanomedicine 8:2141–215110.2147/IJN.S44482 ↗
9. Kim SE, Yun YP, Shim KS, Park K, Choi SW, Suh DH (2014) Effect of lactoferrin-impregnated porous poly(lactide-co-glycolide) (PLGA) microspheres on osteogenic differentiation of rabbit adipose-derived stem cells (rADSCs). Colloids Surf B 122:457–46410.1016/j.colsurfb.2014.06.057 ↗
10. Giovagnoli S, Blasi P, Schoubben A, Rossi C, Ricci M (2007) Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int J Pharm 333:103–11110.1016/j.ijpharm.2006.10.005 ↗
11. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML (1997) Large porous particles for pulmonary drug delivery. Science 276:1868–187110.1126/science.276.5320.1868 ↗
12. Na XM, Gao G, Zhang LY, Su ZG, Ma GH (2012) Biodegradable microcapsules prepared by self-healing of porous microspheres. ACS Macro Lett 1:697–70010.1021/mz200222d ↗
13. Reinhold SE, Schwendeman SP (2013) Effect of polymer porosity on aqueous self-healing encapsulation of proteins in PLGA microspheres. Macromol Biosci 13:1700–171010.1002/mabi.201300323 ↗
14. Reinhold SE, Desai KG, Zhang L, Olsen KF, Schwendeman SP (2012) Self-healing microencapsulation of biomacromolecules without organic solvents. Angew Chem Int Ed Engl 51:10800–1080310.1002/anie.201206387 ↗
15. Feng T, Tian H, Xu C et al. (2014) Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment. Eur J Pharm Biopharm 88:1086–109310.1016/j.ejpb.2014.09.012 ↗
16. Lee J, Oh YJ, Lee SK, Lee KY (2010) Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery. J Control Release 146:61–6710.1016/j.jconrel.2010.05.026 ↗
17. Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y (2009) Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 30:1947–195310.1016/j.biomaterials.2008.12.044 ↗
18. Chou MJ, Hsieh CH, Yeh PL, Chen PC, Wang CH, Huang YY (2013) Application of open porous poly(d,l-lactide-co-glycolide) microspheres and the strategy of hydrophobic seeding in hepatic tissue cultivation. J Biomed Mater Res A 101:2862–286910.1002/jbm.a.34594 ↗
19. Ghanbar H, Luo CJ, Bakhshi P, Day R, Edirisinghe M (2013) Preparation of porous microsphere-scaffolds by electrohydrodynamic forming and thermally induced phase separation. Mater Sci Eng C 33:2488–249810.1016/j.msec.2012.12.098 ↗
20. Chaudhari KR, Shah N, Patel H, Murthy R (2010) Preparation of porous PLGA microspheres with thermoreversible gel to modulate drug release profile of water-soluble drug: bleomycin sulphate. J Microencapsul 27:303–31310.3109/02652040903191818 ↗
21. Bao TQ, Hiep NT, Kim YH, Yang HM, Lee BT (2011) Fabrication and characterization of porous poly(lactic-co-glycolic acid) (PLGA) microspheres for use as a drug delivery system. J Mater Sci 46:2510–2517. doi: 10.1007/s10853-010-5101-410.1007/s10853-010-5101-4 ↗
22. Cocks E, Somavarapu S, Alpar O, Greenleaf D (2014) Influence of suspension stabilizers on the delivery of protein-loaded porous poly(d,l-lactide-co-glycolide) (PLGA) microparticles via pressurized metered dose inhaler (pMDI). Pharm Res 31:2000–200910.1007/s11095-014-1302-x ↗
23. Klose D, Siepmann F, Willart JF, Descamps M, Siepmann J (2010) Drug release from PLGA-based microparticles: effects of the “microparticle:bulk fluid” ratio. Int J Pharm 383:123–13110.1016/j.ijpharm.2009.09.012 ↗
24. Cocks E, Alpar O, Somavarapu S, Greenleaf D (2015) Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery. Drug Dev Ind Pharm 41:522–52810.3109/03639045.2014.884117 ↗
25. Jiang T, Singh B, Li HS et al. (2014) Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Biomaterials 35:2365–237310.1016/j.biomaterials.2013.11.073 ↗
26. Kim TK, Yoon JJ, Lee DS, Park TG (2006) Gas foamed open porous biodegradable polymeric microspheres. Biomaterials 27:152–15910.1016/j.biomaterials.2005.05.081 ↗
27. Chen AZ, Yang YM, Wang SB, Wang GY, Liu YG, Sun QQ (2013) Preparation of methotrexate-loaded, large, highly-porous PLLA microspheres by a high-voltage electrostatic antisolvent process. J Mater Sci Mater Med 24:1917–192510.1007/s10856-013-4942-1 ↗
28. Fang K, Yang F, Zhang Q, Zhang T, Gu N (2014) Fabrication of nonporous and porous cationic PLGA microspheres. Mater Lett 117:86–8910.1016/j.matlet.2013.11.101 ↗
29. Ahmed AR, Bodmeier R (2009) Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. Eur J Pharm Biopharm 71:264–27010.1016/j.ejpb.2008.09.007 ↗
30. Sahoo SK, Panda AK, Labhasetwar V (2005) Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth breast cancer cells. Biomacromolecules 6:1132–113910.1021/bm0492632 ↗
31. Kwon MJ, Bae JH, Kim JJ, Na K, Lee ES (2007) Long acting porous microparticle for pulmonary protein delivery. Int J Pharm 333:5–910.1016/j.ijpharm.2007.01.016 ↗
32. Ungaro F, di Villa d’Emmanuele, Bianca R, Giovino C et al. (2009) Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release 135:25–3410.1016/j.jconrel.2008.12.011 ↗
33. Ehtezazi T, Washington C (2000) Controlled release of macromolecules from PLA microspheres: using porous structure topology. J Control Release 68:361–37210.1016/S0168-3659(00)00270-4 ↗
34. Sun L, Zhou S, Wang W, Li X, Wang J, Weng J (2009) Preparation and characterization of porous biodegradable microspheres used for controlled protein delivery. Colloids Surf A 345:173–18110.1016/j.colsurfa.2009.04.053 ↗
35. Zhang GH, Hou RX, Zhan DX, Cong Y, Cheng YJ, Fu J (2013) Fabrication of hollow porous PLGA microspheres for controlled protein release and promotion of cell compatibility. Chin Chem Lett 24:710–71410.1016/j.cclet.2013.05.011 ↗
36. De Rosa G, Quaglia F, La Rotonda M, Besnard M, Fattal E (2002) Biodegradable microparticles for the controlled delivery of oligonucleotides. Int J Pharm 242:225–22810.1016/S0378-5173(02)00162-X ↗
37. Kang F, Singh J (2001) Effect of additives on the release of a model protein from PLGA microspheres. AAPS PharmSciTech 2:86–9210.1007/BF02830570 ↗
38. Meng B, Li L, Hua S et al. (2010) Effect of medium-chain triglycerides on the release behavior of Endostar encapsulated PLGA microspheres. Int J Pharm 397:136–14310.1016/j.ijpharm.2010.07.018 ↗
39. Takai C, Hotta T, Shiozaki S, Matsumoto S, Fukui T (2011) Effect of inorganic salt on formation of porous PLGA microspheres. Chem Lett 40:638–63910.1246/cl.2011.638 ↗
40. Kim HK, Chung HJ, Park TG (2006) Biodegradable polymeric microspheres with “open/closed” pores for sustained release of human growth hormone. J Control Release 112:167–17410.1016/j.jconrel.2006.02.004 ↗
41. Kim MR, Lee S, Park JK, Cho KY (2010) Golf ball-shaped PLGA microparticles with internal pores fabricated by simple O/W emulsion. Chem Commun 46:7433–743510.1039/c0cc01738h ↗
42. Shi X, Yu H, Li L, Wu H (2013) One-step generation of covered porous PLGA microspheres for controlled delivery and regenerative medicine. J Control Release 172:e14510.1016/j.jconrel.2013.08.236 ↗
43. Hong Y, Gao C, Shi Y, Shen J (2005) Preparation of porous polylactide microspheres by emulsion-solvent evaporation based solution induced phase separation. Polym Adv Technol 16:622–62710.1002/pat.629 ↗
44. Schaefer MJ, Singh J (2002) Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Biomaterials 23:3465–347110.1016/S0142-9612(02)00053-4 ↗
45. Qutachi O, Vetsch JR, Gill D et al. (2010) Injectable and porous PLGA microspheres that form highly porous scaffolds at body temperature. Acta Biomater 10:5090–509810.1016/j.actbio.2014.08.015 ↗
46. Sah H, Lee BJ (2006) Development of new microencapsulation techniques useful for the preparation of PLGA microspheres. Macromol Rapid Commun 27:1845–185110.1002/marc.200600531 ↗
47. Im HY, Sah H (2009) Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent. Int J Pharm 382:130–13810.1016/j.ijpharm.2009.08.020 ↗
48. Sah H (1997) A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres. J Pharm Sci 86:1315–131810.1021/js960363q ↗
49. Wang J, Wang BM, Schwendeman SP (2002) Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres. J Control Release 82:289–30710.1016/S0168-3659(02)00137-2 ↗
50. Desai KG, Schwendeman SP (2013) Active self-healing encapsulation of vaccine antigen in PLGA microspheres. J Control Release 165:62–7410.1016/j.jconrel.2012.10.012 ↗
51. Brange J, Andersen L, Laursen ED, Meyn G, Rasmussen E (1997) Toward understanding insulin fibrillation. J Pharm Sci 86:517–52510.1021/js960297s ↗
52. Go DP, Palmer JA, Mitchell GM, Gras SL, O’Connor AJ (2015) Porous PLGA microspheres tailored for dual delivery of biomolecules via layer-by-layer assembly. J Biomed Mater Res A 105:1849–1863
53. Paik DH, Choi SW (2014) Entrapment of protein using electrosprayed poly(d,l-lactide-co-glycolide) microspheres with a porous structure for sustained release. Macromol Rapid Commun 35:1033–103810.1002/marc.201400042 ↗
54. Félix Lanao RP, Leeuwenburgh SCG, Wolke JGC, Jansen JA (2011) In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. Acta Biomater 7:3459–346810.1016/j.actbio.2011.05.036 ↗
55. Schrier JA, DeLuca PP (2001) Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release. AAPS PharmSciTech 2:66–7210.1208/pt020317 ↗
56. Rawat A, Majumder QH, Ahsan F (2008) Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation. J Control Release 128:224–23210.1016/j.jconrel.2008.03.013 ↗
57. Li X, Chang S, Du G et al. (2012) Encapsulation of azithromycin into polymeric microspheres by reduced pressure–solvent evaporation method. Int J Pharm 433:79–8810.1016/j.ijpharm.2012.04.081 ↗